
    
      This is a Prospective Phase II Study to evaluate Cord Blood Transplantation in Inherited or
      Acquired Severe Aplastic Anemia Refractory or in Relapse after Immunosuppressive Therapy in
      the absence of an Human Leucocyte Antigen (HLA) identical donor; 26 patients will be
      recruited, according to a one step Fleming design
    
  